30 Day Psychedelic Pharmacology Podcast - Day 22 Non-Hallucinogenic Serotonin Agonists

This podcast episode explores non-hallucinogenic serotonin agonists, a promising new direction in psychedelic research. The discussion focuses on compounds that can potentially deliver therapeutic benefits of psychedelics without causing hallucinations, with particular attention to Psilera's PSIL-006 compound.The conversation covers key topics including:- How these compounds work through partial activation of the 5HT2A receptor- Pre-clinical studies showing anxiety reduction without psychedelic effects- Potential applications in treating depression, PTSD, and other disorders- Current challenges in research and development- The broader implications for mental healthcareThe episode features an in-depth discussion of both the molecular mechanisms and broader implications for mental health treatment, while exploring the question of whether the subjective psychedelic experience is necessary for therapeutic benefits.